HomeFranceSofinnova Partners and Gustave Roussy Team Up to Boost Oncology Startup Acceleration...

Sofinnova Partners and Gustave Roussy Team Up to Boost Oncology Startup Acceleration in France

Sofinnova Partners

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, and Gustave Roussy, a Paris, France-based cancer centre, announced the launch of a strategic collaboration as part of Sofinnova Biovelocita (read here), a pan-European investment strategy dedicated to the creation and acceleration of biotech startups.

The alliance will accelerate oncology startups spun out of Gustave Roussy’s integrated research and bring together their strengths to catalyze and accelerate the growth of innovative oncology biotech startups.

Sofinnova Biovelocita is dedicated entirely to the creation and acceleration of biotech startups in Europe. The team will work closely with the best universities and research organizations in Europe to unearth the most promising scientific breakthroughs.

Since its inception in 2000, Gustave Roussy Transfert, Gustave Roussy’s subsidiary dedicated to the development and transfer of technologies, has supported every entrepreneurial initiative that has come out of the institute. Gustave Roussy Transfert now holds a portfolio of 15 companies in fields as varied as biotechnology, artificial intelligence, and nuclear medicine. Gustave Roussy Transfert aims to create and support one or two new oncology startups per year over the next five years within Biovelocita. A first project sourced by Gustave Roussy Transfert and presented to Sofinnova Biovelocita should soon pass through the investment committee, with a first company inception planned for early 2024.

Gustave Roussy is a centre with comprehensive expertise and is devoted entirely to patients suffering with cancer. The Institute, a founding member of the Paris-Saclay Cancer Cluster, is specialized in the treatment of rare cancers and complex tumors and it treats all cancers in patients of any age. Its care is personalized and combines the most advanced medical methods with an appreciation of the patient’s human requirements.